Medical Equipment

ZEISS acquires Ceres Holographics to accelerate holography industrialization

Combining decades-long holography expertise with complementary holographic innovations JENA, Germany, Oct. 8, 2026 /PRNewswire/ -- ZEISS has announced the acquisition of Ceres Holographics, a pioneering holographic technology company headquartered in Livingston, Scotland. Ceres Holographics beco...

2026-10-08 17:12

Flat Medical Surpasses 30 U.S. Hospitals and Pain Centers Using the EpiFaith® Smart Syringe in Routine Clinical Practice

Adoption spans obstetric anesthesia and interventional pain management, as major integrated delivery networks begin groundwork for system-wide conversion AUSTIN, Texas, Oct. 7, 2026 /PRNewswire/ -- Flat Medical, a provider of precision needle access and guidance solutions for anesthesia, critical...

2026-10-07 20:08 2806

Cambridge Heartwear Awarded £184 Million NHS Tender for World's First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable

CAMBRIDGE, England, Oct. 6, 2026 /PRNewswire/ -- Cambridge Heartwear® Limited ( www.camheartwear.com

2026-10-07 01:00 3820

XtalPi Debuts Kodexia™, the World's First Closed-Loop siRNA Platform Combining Generative AI with First-Principles Modeling

* This unified platform integrates sequence design, chemical modification, experimental validation, extrahepatic delivery design, and intellectual property strategy into an integrated computational–experimental workflow, pioneering in vivo efficacy prediction models to accelerate drug developme...

2026-10-06 22:42 4110

Datasea Reports Fiscal Year 2026 Results with Gross Profit Up 70.1% and Gross Margin Increased to 10.2% Despite Lower Revenue

Net Loss Narrowed 57.0% and Operating Cash Flow Turned Positive; Company Also Received an Additional 180-Day Nasdaq Compliance Period BEIJING, Oct. 5, 2026 /PRNewswire/ -- Datasea Intelligent Technology Ltd. (Nasdaq: DTSS) ("Datasea" or the "Company"), a technology company focused on acoustic in...

2026-10-05 22:13 6010

Symphony™ Randomized Controlled Trial Demonstrates Significantly Improved Healing of Diabetic Foot Ulcers

Published multicenter study found higher complete wound closure rates and faster healing with Symphony plus standard of care AUCKLAND, New Zealand, Oct. 5, 2026 /PRNewswire/ -- Aroa Biosurgery Limited (ASX: ARX), a soft tissue regeneration company, today announced positive results from a prospec...

2026-10-05 12:46 2249

Celaid Therapeutics Completes Second Close of Series B Financing Round

Shionogi & Co., Ltd. and Teikoku Ventures, Inc. Join the Round to Accelerate  U.S. Clinical Trial Preparations for CLD-001 TOKYO, Oct. 4, 2026 /PRNewswire/ -- Celaid Therapeutics Inc. (Head Office: Bunkyo-ku, Tokyo, Japan; President and CEO: Nobuyuki Arakawa; "Celaid") today announced the complet...

2026-10-05 09:30 1640

Advances in Digital Therapeutics and HoneyNaps AI Enhance Clinical Trial Efficiency

* Supporting pharmaceutical, medical device, wellness, and research organizations in obtaining standardized sleep data * Expanding the use of SOMNUM scoring technology to provide clinical analysis services tailored to each customer's research objectives * AI Technologies Supporting Global...

2026-10-01 19:00 2715

POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization

GUANGZHOU, China, Sept. 30, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions, today provided an update on the continued progress in the development and commercialization of its AI...

2026-09-30 20:00 1630

2026 International Day of Older Persons: Dimora Medical Supports Dignified Longevity with Advanced Home Wound Care

NEW YORK, Sept. 29, 2026 /PRNewswire/ -- As the world observes the 2026 United Nations International Day of Older Persons under the theme "The Age of Longevity: Rethinking Systems for Longer Lives ," global attention is turning toward ...

2026-09-30 01:50 2255

Yuyu Teijin Medicare Uses Drones to Deliver Medical Supplies to Patients on Korea's Remote Islands

SEOUL, South Korea, Sept. 29, 2026 /PRNewswire/ -- Yuyu Teijin Medicare, a home healthcare joint venture between Yuyu Pharma of Korea and Teijin Pharma of Japan, has completed a pilot delivery of medical supplies by drone to a ventilator patient living on a remote Korean island. In the test, a d...

2026-09-29 21:00 2006

Elsevier launches ClinicalKey Nursing AI, a new evidenced-based clinical AI solution built specifically for nurses

Developed to fit around nursing workflows, ClinicalKey Nursing AI gives nurses fast, traceable answers to clinical questions at the point of care. NEW YORK, Sept. 29, 2026 /PRNewswire/ -- Today Elsevier announced the global launch of ClinicalKey Nursing AI, the clinical AI tool built specifically...

2026-09-29 20:00 2264

Hengrui Pharma and Novo Enter Exclusive License Agreement for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596

* HRS-1596 is a phase I-ready GLP-1/GIP dual receptor agonist for once-weekly oral dosing           * Total potential deal value is up to 2.6 billion US dollars, including 300 million dollars upfront, as well as potential sales royalties SHANGHAI, Sept. 29, 2026 /PRNewswire/ -- Hengrui Pharm...

2026-09-29 13:12 2046

Open-Source Model Accelerates Global Progress in Medical Video AI

SHANGHAI, Sept. 28, 2026 /PRNewswire/ -- Through an open-source model, a public dataset and benchmark, and the MedVidU Challenge, a global research competition, researchers worldwide now share a common foundation for advancing medical video AI. The Challenge drew 75 teams from 18 countries and re...

2026-09-28 21:19 3460

Lunit Expands AI-Powered Breast Cancer Screening Across the Stockholm Region

Following years of clinical validation and proven real-world performance at Saint Göran, Stockholm Region adopts Lunit INSIGHT MMG as an independent second reader at regional scale SEOUL, South Korea, Sept. 28, 2026 /PRNewswire/ -- Lunit (KRX:328130), a leading provider of AI for cancer diagnost...

2026-09-28 21:00 2288

SOLA Biosciences Japan Receives AMED Grant to Advance SOL-257, Innovative Gene Therapy Aiming to Restore TDP-43 Function for ALS Patients

TOKYO and BOSTON, Sept. 28, 2026 /PRNewswire/ -- SOLA Biosciences Japan GK ("SOLA Japan"), the wholly owned Japanese subsidiary of Boston-based SOLA Biosciences Inc. (together, "SOLA"), announced that it has been awarded a grant of approximately 6 billion yen over five years by the Japan Agency f...

2026-09-28 14:00 2342

GROWNSY Makes NANN Conference Debut, Partners with NANN and Pediatrician Dr. Molly O'Shea on NANNcast Episode Tackling Infant Nasal Congestion

The company exhibited for the first time at NANN's 42nd Annual Conference in West Palm Beach and will sponsor a NANNcast episode exploring why newborns are so vulnerable to nasal congestion — and what neonatal nurses and parents can do about it. NEW YORK, Sept. 22, 2026 /PRNewswire/ -- GROWNSY <...

2026-09-23 09:36 916

BoomRay Enters Exclusive Global License Agreement with Novartis for a Novel Radioligand Therapy Asset

SUZHOU, China, Sept. 22, 2026 /PRNewswire/ -- Boomray Pharmaceuticals Co., Ltd. ("BoomRay"), a clinical-stage biotechnology company pioneering innovative radioligand therapies (RLTs) for precision oncology diagnostics and therapeutics, today announced that it has entered into an exclusive global ...

2026-09-22 12:00 2054

NAVER D2SF Invests in AI-Driven Precision Medicine Company ImpriMed

* ImpriMed combines ex vivo functional testing with multimodal AI to support personalized cancer treatment decisions and drug development * The investment is part of ImpriMed's $10 million Series A2 bridge round as the company advances U.S. commercialization and expands into Asia * NAVER D2S...

2026-09-18 23:00 3502

Dr. Alison Armour agrees to become Chief Medical Officer of Alpha Fusion, as Company Advances Integration of At-211 Businesses with Curadh MTR

— Combining Both Companies' Astatine At-211 Assets, Development Capabilities, and Supply Chains to Create a Global Targeted Alpha Therapy Company — TOKYO, Sept. 17, 2026 /PRNewswire/ -- Alpha Fusion Inc. ("Alpha Fusion"), a clinical-stage company with an advanced At-211 drug platform, and Curadh ...

2026-09-17 19:00 2489
12345 ... 53